R&D shift seeks to leverage image quality to cut dose
A dramatic shift in R&D toward patient safety has taken place in the CT industry, a shift most clearly seen in efforts to reduce patient radiation dose. Iterative reconstruction algorithms are a prominent fixture at the ISCT meeting this year, as they and their future development are increasingly seen as providing the means to cut dose, while maintaining or even boosting image quality.
A dramatic shift in R&D toward patient safety has taken place in the CT industry, a shift most clearly seen in efforts to reduce patient radiation dose. Iterative reconstruction algorithms are a prominent fixture at the ISCT meeting this year, as they and their future development are increasingly seen as providing the means to cut dose, while maintaining or even boosting image quality.
In the past, vendors have emphasized image quality alone, looking for ways to improve diagnostic confidence or add clinical applications. But with increasing attention being paid to patient dose, vendors have sought to leverage this software to maintain the current benchmark of image quality and reduce dose.
They have documented that iterative reconstruction algorithms can be used to clean up noisy images, producing scans of the same image quality as before, but with less radiation. GE Healthcare pioneered this approach, unveiling the idea at RSNA 2008 with its Adaptive Statistical Iterative Reconstruction product. Dose reductions of 50% or more have since been demonstrated in clinical use, according to the company.
More recently, Siemens and Philips have followed suit, Siemens through its IRIS (Iterative Reconstruction in Image Space) and Philips through its iDose. Toshiba is also developing an iterative reconstruction algorithm. GE is developing a next-generation Model-Based Iterative Reconstruction.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
